A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study : Lancet Infect Dis,2019Sep27
Cantaert T, Borand L, Kergoat L, Leng C, Ung S, In S, Peng Y, Phoeun C, Hing C, Taing CN, Saman M, Ong S, Mey C, Choeung R, Ly S, Dussart P, Bourhy H, Tarantola A.
A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2)
Lancet Infect Dis. 2019 Sep 27. pii: S1473-3099(19)30311-1. doi: 10.1016/S1473-3099(19)30311-1.